<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8806548</journal-id>
<journal-id journal-id-type="pubmed-jr-id">21560</journal-id>
<journal-id journal-id-type="nlm-ta">Clin Neuropsychol</journal-id>
<journal-id journal-id-type="iso-abbrev">Clin Neuropsychol</journal-id>
<journal-title-group>
<journal-title>The Clinical neuropsychologist</journal-title>
</journal-title-group>
<issn pub-type="ppub">1385-4046</issn>
<issn pub-type="epub">1744-4144</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27355445</article-id>
<article-id pub-id-type="pmc">5004987</article-id>
<article-id pub-id-type="doi">10.1080/13854046.2016.1189536</article-id>
<article-id pub-id-type="manuscript">NIHMS812195</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>BROAD AUTISM SPECTRUM AND OBSESSIVE COMPULSIVE SYMPTOMS IN ADULTS WITH THE FRAGILE X PREMUTATION</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Schneider</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Johnston</surname>
<given-names>C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tassone</surname>
<given-names>F.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sansone</surname>
<given-names>S.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hagerman</surname>
<given-names>R.J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ferrer</surname>
<given-names>E.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rivera</surname>
<given-names>S.M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hessl</surname>
<given-names>D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>MIND Institute, UC Davis Medical Center, Sacramento, CA</aff>
<aff id="A2"><label>2</label>Department of Psychiatry and Behavioral Sciences, UC Davis School of Medicine, Sacramento, CA</aff>
<aff id="A3"><label>3</label>Department of Pediatrics, UC Davis School of Medicine, Sacramento, CA</aff>
<aff id="A4"><label>4</label>Department of Psychology, UC Davis, Davis, CA</aff>
<aff id="A5"><label>5</label>Center for Mind and Brain, UC Davis, Davis, CA</aff>
<aff id="A6"><label>6</label>Department of Biochemistry and Molecular Medicine, UC Davis, Davis, CA</aff>
<aff id="A7"><label>7</label>Department of Human Development, UC Davis, Davis, CA</aff>
<author-notes>
<corresp id="FN1">Corresponding author: Andrea Schneider, PhD., UC Davis MIND Institute, 2825 50<sup>th</sup> Street, Sacramento, CA 95817, <email>anschneider@ucdavis.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2017</year>
</pub-date>
<volume>30</volume>
<issue>6</issue>
<fpage>929</fpage>
<lpage>943</lpage>
<!--elocation-id from pubmed: 10.1080/13854046.2016.1189536-->
<abstract>
<sec id="S1">
<title>Objective</title>
<p id="P1">Clinical observations and a limited number of research studies provide evidence that the fragile X premutation may confer risk for autism, executive dysfunction, and psychopathology. The link to autism spectrum symptoms and social cognition deficits with the premutation remains uncertain, and thus was the focus of the present investigation.</p>
</sec>
<sec id="S2">
<title>Method</title>
<p id="P2">Our sample included 131 individuals, 42 men/22 women with the <italic>FMR1</italic> premutation (mean age = 31.83 ± 8.59 years) with a normal neurological exam, and 48 men/19 women healthy age matched controls (mean age = 29.48 ± 7.29 years). Individuals completed a comprehensive neuropsychological battery with additional assessments for social cognition, broad autism spectrum, and obsessive-compulsive (OC) symptoms.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">Premutation carriers self-reported higher rates of autism-related symptoms (Autism Quotient; p=.001). Among males only, premutation carriers showed more atypical social interaction (p&lt;.001) and stereotyped behavior (p=.014) during standardized clinical examination on the Autism Diagnostic Observation Schedule (ADOS) relative to controls. Female premutation carriers reported significantly higher rates of OC symptoms compared to control females (p=.012). Molecular measures defining the expanded premutation (<italic>FMR1</italic> CGG repeat length and/or mRNA) were significantly associated with a measure of theory of mind (Reading the Mind in the Eyes Task).</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">The results of this study indicate a higher rate of broad autism spectrum symptoms in some males with the premutation and provide evidence for an obsessive-compulsive subtype in female premutation carriers.</p>
</sec>
</abstract>
<kwd-group>
<kwd>social cognition</kwd>
<kwd>fragile X premutation</kwd>
<kwd>broad autism spectrum phenotype</kwd>
<kwd>obsessive compulsive disorder</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>